Lisata Therapeutics, Inc. (LSTA) vs Pluri Inc. (PLUR)
Lisata Therapeutics, Inc. and Pluri Inc. are both Biotechnology companies. Lisata Therapeutics, Inc. and Pluri Inc. are of similar size ($13.5M and $13.0M). Pluri Inc. grew revenue faster over the last twelve months: −24.0% against −24.7%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 17 metrics below, Lisata Therapeutics, Inc. leads on 9 and Pluri Inc. on 8.
Valuation
Profitability
| Metric | LSTA | PLUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.49% | 44.59% | 65.16% |
| Operating margin | 0.00% | (2,454.53%) | 0.00% |
| Net margin | 0.00% | (2,344.59%) | 0.00% |
| Free cash flow margin | 0.00% | (1,988.48%) | 0.00% |
| Return on equity | (101.66%) | 260.35% | (57.72%) |
| Return on assets | (80.81%) | (74.95%) | (49.22%) |
| Return on invested capital | 0.00% | (526.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack